- Home
- MNPR vs LAKE Comparison
MNPR vs LAKE Comparison
Compare MNPR & LAKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- LAKE
- Stock Information
- Founded
- MNPR 2014
- LAKE 1982
- Country
- MNPR United States
- LAKE United States
- Employees
- MNPR N/A
- LAKE N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- LAKE Industrial Specialties
- Sector
- MNPR Health Care
- LAKE Health Care
- Exchange
- MNPR Nasdaq
- LAKE Nasdaq
- Market Cap
- MNPR 250.0M
- LAKE 234.8M
- IPO Year
- MNPR 2019
- LAKE 1986
- Fundamental
- Price
- MNPR $40.25
- LAKE $24.72
- Analyst Decision
- MNPR Strong Buy
- LAKE Strong Buy
- Analyst Count
- MNPR 4
- LAKE 2
- Target Price
- MNPR $43.00
- LAKE $27.50
- AVG Volume (30 Days)
- MNPR 71.2K
- LAKE 90.7K
- Earning Date
- MNPR 03-27-2025
- LAKE 04-09-2025
- Dividend Yield
- MNPR N/A
- LAKE 0.49%
- EPS Growth
- MNPR N/A
- LAKE N/A
- EPS
- MNPR N/A
- LAKE N/A
- Revenue
- MNPR N/A
- LAKE $151,822,000.00
- Revenue This Year
- MNPR N/A
- LAKE $37.18
- Revenue Next Year
- MNPR N/A
- LAKE $22.27
- P/E Ratio
- MNPR N/A
- LAKE N/A
- Revenue Growth
- MNPR N/A
- LAKE 23.99
- 52 Week Low
- MNPR $1.72
- LAKE $15.10
- 52 Week High
- MNPR $54.30
- LAKE $27.28
- Technical
- Relative Strength Index (RSI)
- MNPR 49.34
- LAKE 54.44
- Support Level
- MNPR $38.80
- LAKE $23.86
- Resistance Level
- MNPR $45.60
- LAKE $25.53
- Average True Range (ATR)
- MNPR 5.19
- LAKE 0.97
- MACD
- MNPR -1.50
- LAKE 0.13
- Stochastic Oscillator
- MNPR 9.37
- LAKE 75.38
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About LAKE Lakeland Industries Inc.
Lakeland Industries Inc manufactures and sells safety garments and accessories for the industrial protective clothing market. Its product segments include Disposables, Chemicals, Fire, Gloves, High Visibility, High-Performance Wear, and Wovens. Its customers include integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, and mortuaries, as well as scientific and medical laboratories. Its geographical segments include the United States, Latin America, Canada, Asia, Mexico, Europe (United Kingdom), and Other Foreign.